DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Gerstein HC, Colhoun HM, Dagenais GR. for the REWIND Investigators. et al.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet 2019;
394: 121-130
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.